$1.45 Billion is the total value of Novo Holdings A/S's 35 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 30.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASML | Sell | ASML HOLDING N V | $177,145,712 | +18.3% | 182,536 | -7.7% | 12.22% | +32.2% |
| BROOKFIELD CORPcl a ltd vt sh | $162,465,230 | +4.4% | 3,880,230 | 0.0% | 11.21% | +16.6% | ||
| CRM | Sell | SALESFORCE INC | $144,614,589 | +3.6% | 480,160 | -9.5% | 9.98% | +15.7% |
| EPC | New | EDGEWISE THERAPEUTICS INC | $115,722,403 | – | 6,344,430 | +100.0% | 7.98% | – |
| CORT | CORCEPT THERAPEUTICS INC | $60,742,209 | -22.4% | 2,411,362 | 0.0% | 4.19% | -13.4% | |
| PCVX | VAXCYTE INC | $57,721,950 | +8.8% | 845,000 | 0.0% | 3.98% | +21.5% | |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $51,425,466 | +31.4% | 1,098,600 | -0.1% | 3.55% | +46.8% |
| CABO | CABLE ONE INC | $50,099,861 | -24.0% | 118,403 | 0.0% | 3.46% | -15.1% | |
| LANZATECH GLOBAL INC | $48,946,945 | -38.5% | 15,814,845 | 0.0% | 3.38% | -31.3% | ||
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $44,604,000 | +46.8% | 1,400,000 | -6.7% | 3.08% | +63.9% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $39,303,000 | -9.4% | 450,000 | 0.0% | 2.71% | +1.2% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $37,680,000 | -14.9% | 1,500,000 | 0.0% | 2.60% | -4.9% | |
| INSM | INSMED INC | $36,335,318 | -12.5% | 1,339,304 | 0.0% | 2.51% | -2.2% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $36,239,842 | -6.6% | 500,827 | 0.0% | 2.50% | +4.3% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $34,019,262 | +2.7% | 358,626 | -0.1% | 2.35% | +14.7% |
| AAPL | Sell | APPLE INC | $31,373,981 | -26.4% | 182,960 | -17.4% | 2.16% | -17.8% |
| FOLD | AMICUS THERAPEUTICS INC | $29,450,000 | -17.0% | 2,500,000 | 0.0% | 2.03% | -7.3% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $28,287,000 | -10.1% | 1,050,000 | 0.0% | 1.95% | +0.4% | |
| CARGO THERAPEUTICS INC | $27,900,000 | -3.6% | 1,250,000 | 0.0% | 1.92% | +7.7% | ||
| PHVS | Sell | PHARVARIS N V | $26,993,173 | -37.5% | 1,168,030 | -24.1% | 1.86% | -30.2% |
| VERV | VERVE THERAPEUTICS INC | $26,560,000 | -4.7% | 2,000,000 | 0.0% | 1.83% | +6.4% | |
| BROOKFIELD ASSET MANAGMT LTD | $26,355,238 | +4.6% | 627,207 | 0.0% | 1.82% | +16.8% | ||
| Buy | LEXEO THERAPEUTICS INC | $25,688,513 | +46.4% | 1,638,298 | +25.3% | 1.77% | +63.5% | |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $19,261,000 | – | 1,100,000 | +100.0% | 1.33% | – |
| New | ARRIVENT BIOPHARMA INC | $19,237,720 | – | 1,077,140 | +100.0% | 1.33% | – | |
| New | METAGENOMI INC | $18,348,296 | – | 1,739,175 | +100.0% | 1.27% | – | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $17,692,339 | -21.9% | 118,383 | 0.0% | 1.22% | -12.8% | |
| New | KYVERNA THERAPEUTICS INC | $17,388,000 | – | 700,000 | +100.0% | 1.20% | – | |
| INSP | INSPIRE MED SYS INC | $14,073,900 | +5.6% | 65,524 | 0.0% | 0.97% | +18.0% | |
| Sell | IO BIOTECH INC | $8,802,686 | -18.5% | 5,088,258 | -11.5% | 0.61% | -9.0% | |
| ABCL | ABCELLERA BIOLOGICS INC | $5,104,925 | -20.7% | 1,126,915 | 0.0% | 0.35% | -11.3% | |
| TMCI | TREACE MED CONCEPTS INC | $4,698,000 | +2.4% | 360,000 | 0.0% | 0.32% | +14.5% | |
| MQ | MARQETA INC | $2,631,686 | -14.6% | 441,558 | 0.0% | 0.18% | -4.2% | |
| GLTO | GALECTO INC | $1,948,277 | +8.3% | 2,497,791 | 0.0% | 0.13% | +20.7% | |
| SPRO | SPERO THERAPEUTICS INC | $806,511 | -99.3% | 468,902 | 0.0% | 0.06% | -99.3% | |
| LVTX | Exit | LAVA THERAPEUTICS NV | $0 | – | -1,878,194 | -100.0% | -0.18% | – |
| Exit | RALLYBIO CORP | $0 | – | -1,767,861 | -100.0% | -0.26% | – | |
| SPRB | Exit | SPRUCE BIOSCIENCES INC | $0 | – | -6,722,336 | -100.0% | -1.22% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -900,000 | -100.0% | -1.31% | – |
| EWTX | Exit | EDGEWISE THERAPEUTICS INC | $0 | – | -6,071,703 | -100.0% | -4.10% | – |
| TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $0 | – | -710,780 | -100.0% | -4.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 25 | Q2 2024 | 4.1% |
| CABLE ONE INC | 22 | Q2 2024 | 9.7% |
| BLUEPRINT MEDICINES CORP | 22 | Q2 2024 | 2.3% |
| INSPIRE MED SYS INC | 22 | Q1 2024 | 1.8% |
| APPLE INC | 21 | Q2 2024 | 10.3% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| CRINETICS PHARMACEUTICALS IN | 21 | Q2 2024 | 3.5% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Galecto, Inc. | June 24, 2024 | 2,497,791 | 9.2% |
| IO Biotech, Inc. | May 14, 2024 | 6,898,584 | 10.1% |
| SPRUCE BIOSCIENCES, INC. | March 28, 2024 | 1,656,000 | 3.9% |
| LAVA Therapeutics NVSold out | March 07, 2024 | 0 | 0.0% |
| Evotec SE | February 14, 2024 | 14,931,858 | 8.4% |
| Edgewise Therapeutics, Inc. | January 25, 2024 | 6,344,430 | 7.4% |
| Rallybio Corp | January 02, 2024 | 1,767,861 | 4.7% |
| Lexeo Therapeutics, Inc. | December 15, 2023 | 1,307,829 | 4.9% |
| Reneo Pharmaceuticals, Inc.Sold out | December 15, 2023 | 0 | 0.0% |
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-09-17 |
| 144 | 2024-09-11 |
| N-PX | 2024-08-23 |
| 13F-HR/A | 2024-08-20 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-07-26 |
| 144 | 2024-07-25 |
| SC 13D/A | 2024-06-24 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-14 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.